Antimony-based substances have good prospects as anode materials in sodium-ion batteries (SIBs) because of their great hypothetical capacity. Unfortunately, the high volumetric growth and limited ion conduction in the electrolytic procedure prevent them from meeting their theoretical capabilities.
In a study published in the journal Carbon, H2/C heat reduction, selenization and sulfurization (SAS) of sodium stibogluconate resulted in Sb2Se3@C and Sb2S3@C nanodots with consistent diameters of 20.7 nm and 19 nm, respectively.
Antimony-based Materials for Sodium-Ion Batteries
Many attempts have been made to investigate suitable electrode substances for sodium-ion batteries (SIBs). Because of their increased capacities compared to anode materials based on intercalation, alloying and conversion-based electrode substances have gained popularity.
Antimony-based substances (Sb, SnSb, Sb2Se3, Sb2S3) are possible anode substances for sodium-ion batteries having unique electrolytic mechanisms and significant hypothetical capacities. Owing to their large hypothetical specific capacities, Sb2Se3 and Sb2S3 are particularly appealing options.
Unfortunately, considerable volumetric growth and inadequate ionic conduction in their electrochemical process are the two fundamental issues that cause quick capacity degradation and poor rate performance at high current density.
Sb2Se3 and Sb2S3 are chalcogenides based on antimony with differing anions, resulting in variations in makeup and conduction. Studies of the influence of various anions on the volumetric growth of the electrode morphology, the capacity to attach with sodium ions (Na+) in the charging/discharging phase, and ionic conduction are of particular importance in the development of electrode components for sodium-ion batteries.
Given that both substances have quick capacity degradation and poor rate performance, avoiding failure of the structure and enhancing electrode conductance are considered primary goals.
Addressing the Limitations of Antimony-based Materials
In general, logical structural design and carbon encapsulation are excellent solutions to these critical issues. Using nanoscale materials may reduce ionic diffusion paths and speed up the interchange of electrons and Na+ ions.
During insertion/removal of sodium ions, the composite carbon is advantageous for accelerating electron transport and improving structural integrity. As a result, a range of Sb2Se3@C and Sb2S3@C composites have been investigated for sodium-ion batteries.
Sb2Se3 nanowires, rod-shaped Sb2S3, and Sb2S3@PPy micro-clips have all been documented thus far. While beneficial electrolytic performance has been achieved, the short cyclic life and extensive examination of the relationship between morphology and Na storing efficiency need additional investigation.
A suitable technique for obtaining extended cyclic life has been proposed to be the construction of an interlinked conducting carbon framework outside of the standalone nanodots (NDs).
Analysis Techniques Used in the Study
Power X-ray diffraction (XRD) was used to describe the crystallographic characteristics. The existence of amorphous carbon with sulfur or selenium loading was verified by Raman spectroscopy, and the amount of amorphous carbon was validated by thermogravimetric assessment.
Transmission electron microscopy (TEM) imaging was used to indicate the unique morphological makeup and distribution of particle sizes. The electrolytic capabilities of the two electrodes for sodium-ion batteries were evaluated using galvanostatic charging/discharging experiments. Density functional theory (DFT) computations were performed to further validate on an atomic level the sodium ion storing kinetics.
Important Findings
In this study, the team synthesized Sb2X3 (where X is Se or S) NDs@C from sodium stibogluconate using a complex pyrolytic technique and utilized them as anode components for sodium-ion batteries. Nanodots having particle sizes of around 19-21 nanometers were encased in a conducting carbon framework loaded with selenium or sulfur.
Each Sb2Se3 and Sb2S3 nanodot was covered by a weakly graphitized interlinking carbon matrix, which was then crosslinked to generate a highly conductive framework.
The reversible capacity displayed by the Sb2Se3 NDs@C electrode was about 316 mA h g-1 following 100 cycles at 100 mA g-1 and about 269 mA h g-1 following 200 cycles at 1 A g-1.
The extremely small nanodot architecture, limited shielding of the crosslinked carbon framework, superior electric conductance, and reduced hypothetical volumetric growth throughout the recurring alloying and converting operations all contributed to the improved electrolytic performance.
Density functional theory computations revealed that Sb2Se3 NDs@C has a lower sodium ion diffusion energy threshold, stronger product-carbon bonding, and more vacant energy bands, which should result in more solid sodium ion storing kinetics and rate performance.
Given the ease of manufacturing, good yield, cheap cost, and excellent electrolytic performance, this research may pave the way for developing upscaled multifunction electrodes using Sb-based coordination compounds in zero to three dimensions.
News
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]















